Royalty Pharma Shares (Basic) increased by 1.1% to 436.8M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.3%, from 435.5M to 436.8M.
Changes reflect share buybacks (decrease) or equity issuance (increase), which impact the per-share earnings calculation.
The average number of common shares outstanding during the reporting period, calculated by weighting the number of share...
Standard metric for all public companies; reflects capital structure and share repurchase activity.
weighted_shares_basic| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 409.3M | 428.2M | 5.5M | 434M | 436.3M | 439.3M | 1.4M | 445.6M | 450.4M | 448.4M | 448.6M | 451M | 447.6M | 435.5M | 423.5M | 431.9M | 436.8M |
| QoQ Change | — | +4.6% | -98.7% | >999% | +0.5% | +0.7% | -99.7% | >999% | +1.1% | -0.4% | +0.0% | +0.5% | -0.8% | -2.7% | -2.7% | +2.0% | +1.1% |
| YoY Change | — | — | — | — | +6.6% | +2.6% | -74.4% | +2.7% | +3.2% | +2.1% | +0.7% | +0.1% | -0.2% | -2.9% | -6.1% | -3.5% | +0.3% |